Prediction of high-grade cervical intraepithelial neoplasia in cytologically normal women by human papillomavirusesting View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2000-11-22

AUTHORS

F Carozzi, G Ronco, M Confortini, D Noferini, C Maddau, S Ciatto, N Segnan

ABSTRACT

Human papillomavirus (HPV) testing has been suggested for primary screening of cervical cancer. Prediction of future high-grade cervical lesions is crucial for effectiveness and cost. We performed a case control study in a retrospective cohort of women with at least two cervical smears, all but the last one being negative, from the organized cervical screening programme in Florence, Italy. We searched for high-risk HPV in all previous, archival, smears from cases (new histologically confirmed cervical intraepithelial neoplasia (CIN) grade II or worse) and in one previous smear from each control (last smear cytologically normal, matched by age and interval (latency) from last smear). We applied polymerase chain reaction (PCR), and the b-globin gene was used as a DNA preservation marker. High-risk HPV was identified in 71/92 (77.17%) previous smears from 79 cases and 17/332 controls (5.12%). The odds ratio (OR) was 63.76 (95% CI 30.57-132.96). Among cases the proportion of HPV-positive smears declined slightly with increasing latency. Among cases, HPV was found in 81.24% (95% CI 69.93-88.96%) of smears with latency < 4 years and in 67.80% (95% CI 47.72-82.93%) of those taken at longer intervals, up to 6 years. These findings suggest that testing for high-risk HPV allows predicting 80% of CINII/III 3 years before the cytological diagnosis and two thirds 6 years before. They also suggest that testing women negative for high-risk HPV at longer interval and strictly following-up women who are HPV positive could be an effective strategy for cervical cancer screening. More... »

PAGES

1462-1467

Identifiers

URI

http://scigraph.springernature.com/pub.10.1054/bjoc.2000.1491

DOI

http://dx.doi.org/10.1054/bjoc.2000.1491

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1007954422

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/11076654


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1117", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Public Health and Health Services", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Case-Control Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cervical Intraepithelial Neoplasia", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cervix Uteri", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "DNA, Viral", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Globins", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Papillomaviridae", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Papillomavirus Infections", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Predictive Value of Tests", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Retrospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Time Factors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Tumor Virus Infections", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Uterine Cervical Neoplasms", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Cytology Unit, Centre for Cancer Study and Prevention (CSPO), Firenze, Italy", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Cytology Unit, Centre for Cancer Study and Prevention (CSPO), Firenze, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Carozzi", 
        "givenName": "F", 
        "id": "sg:person.0673306461.39", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0673306461.39"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Cancer Epidemiology Unit, ASL TO1, Centre for Cancer Epidemiology and Prevention (CPO), Torino, Italy", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Cancer Epidemiology Unit, ASL TO1, Centre for Cancer Epidemiology and Prevention (CPO), Torino, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ronco", 
        "givenName": "G", 
        "id": "sg:person.01206540103.18", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01206540103.18"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Cytology Unit, Centre for Cancer Study and Prevention (CSPO), Firenze, Italy", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Cytology Unit, Centre for Cancer Study and Prevention (CSPO), Firenze, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Confortini", 
        "givenName": "M", 
        "id": "sg:person.0667445361.38", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0667445361.38"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Cytology Unit, Centre for Cancer Study and Prevention (CSPO), Firenze, Italy", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Cytology Unit, Centre for Cancer Study and Prevention (CSPO), Firenze, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Noferini", 
        "givenName": "D", 
        "id": "sg:person.01303355111.07", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01303355111.07"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Cytology Unit, Centre for Cancer Study and Prevention (CSPO), Firenze, Italy", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Cytology Unit, Centre for Cancer Study and Prevention (CSPO), Firenze, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Maddau", 
        "givenName": "C", 
        "id": "sg:person.01116545420.18", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01116545420.18"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Diagnostic Medical Imaging, Centre for Cancer Study and Prevention (CSPO), Florence, Italy", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Department of Diagnostic Medical Imaging, Centre for Cancer Study and Prevention (CSPO), Florence, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ciatto", 
        "givenName": "S", 
        "id": "sg:person.01174274056.26", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01174274056.26"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Cancer Epidemiology Unit, ASL TO1, Centre for Cancer Epidemiology and Prevention (CPO), Torino, Italy", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Cancer Epidemiology Unit, ASL TO1, Centre for Cancer Epidemiology and Prevention (CPO), Torino, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Segnan", 
        "givenName": "N", 
        "id": "sg:person.0743542266.47", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0743542266.47"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/bjc.1995.347", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010276001", 
          "https://doi.org/10.1038/bjc.1995.347"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.bjc.6690730", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011080887", 
          "https://doi.org/10.1038/sj.bjc.6690730"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/bjc.1991.350", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042218657", 
          "https://doi.org/10.1038/bjc.1991.350"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/bjc.1989.236", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022777795", 
          "https://doi.org/10.1038/bjc.1989.236"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/bjc.1997.440", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010481383", 
          "https://doi.org/10.1038/bjc.1997.440"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.bjc.6690523", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041726872", 
          "https://doi.org/10.1038/sj.bjc.6690523"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00051652", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032711152", 
          "https://doi.org/10.1007/bf00051652"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2000-11-22", 
    "datePublishedReg": "2000-11-22", 
    "description": "Human papillomavirus (HPV) testing has been suggested for primary screening of cervical cancer. Prediction of future high-grade cervical lesions is crucial for effectiveness and cost. We performed a case control study in a retrospective cohort of women with at least two cervical smears, all but the last one being negative, from the organized cervical screening programme in Florence, Italy. We searched for high-risk HPV in all previous, archival, smears from cases (new histologically confirmed cervical intraepithelial neoplasia (CIN) grade II or worse) and in one previous smear from each control (last smear cytologically normal, matched by age and interval (latency) from last smear). We applied polymerase chain reaction (PCR), and the b-globin gene was used as a DNA preservation marker. High-risk HPV was identified in 71/92 (77.17%) previous smears from 79 cases and 17/332 controls (5.12%). The odds ratio (OR) was 63.76 (95% CI 30.57-132.96). Among cases the proportion of HPV-positive smears declined slightly with increasing latency. Among cases, HPV was found in 81.24% (95% CI 69.93-88.96%) of smears with latency < 4 years and in 67.80% (95% CI 47.72-82.93%) of those taken at longer intervals, up to 6 years. These findings suggest that testing for high-risk HPV allows predicting 80% of CINII/III 3 years before the cytological diagnosis and two thirds 6 years before. They also suggest that testing women negative for high-risk HPV at longer interval and strictly following-up women who are HPV positive could be an effective strategy for cervical cancer screening.", 
    "genre": "article", 
    "id": "sg:pub.10.1054/bjoc.2000.1491", 
    "inLanguage": "en", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1017082", 
        "issn": [
          "0007-0920", 
          "1532-1827"
        ], 
        "name": "British Journal of Cancer", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "11", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "83"
      }
    ], 
    "keywords": [
      "high-risk HPV", 
      "previous smears", 
      "odds ratio", 
      "polymerase chain reaction", 
      "high-grade cervical intraepithelial neoplasia", 
      "high-grade cervical lesions", 
      "HPV-positive smears", 
      "case control study", 
      "cervical cancer screening", 
      "human papillomavirus testing", 
      "cervical intraepithelial neoplasia", 
      "cervical screening programme", 
      "longer intervals", 
      "retrospective cohort", 
      "intraepithelial neoplasia", 
      "normal women", 
      "cervical cancer", 
      "cancer screening", 
      "cervical lesions", 
      "screening program", 
      "control study", 
      "cervical smears", 
      "HPV", 
      "cytological diagnosis", 
      "smears", 
      "women", 
      "chain reaction", 
      "primary screening", 
      "years", 
      "effective strategy", 
      "screening", 
      "neoplasia", 
      "cohort", 
      "lesions", 
      "cases", 
      "cancer", 
      "diagnosis", 
      "latency", 
      "intervals", 
      "control", 
      "testing", 
      "markers", 
      "findings", 
      "proportion", 
      "study", 
      "genes", 
      "program", 
      "strategies", 
      "effectiveness", 
      "ratio", 
      "globin genes", 
      "Italy", 
      "last one", 
      "reaction", 
      "Florence", 
      "cost", 
      "prediction", 
      "one", 
      "archival", 
      "papillomavirus (HPV) testing", 
      "future high-grade cervical lesions", 
      "DNA preservation marker", 
      "preservation marker", 
      "CINII/III 3 years", 
      "III 3 years", 
      "thirds 6 years", 
      "human papillomavirusesting", 
      "papillomavirusesting"
    ], 
    "name": "Prediction of high-grade cervical intraepithelial neoplasia in cytologically normal women by human papillomavirusesting", 
    "pagination": "1462-1467", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1007954422"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1054/bjoc.2000.1491"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "11076654"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1054/bjoc.2000.1491", 
      "https://app.dimensions.ai/details/publication/pub.1007954422"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-01-01T18:09", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220101/entities/gbq_results/article/article_311.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1054/bjoc.2000.1491"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1054/bjoc.2000.1491'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1054/bjoc.2000.1491'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1054/bjoc.2000.1491'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1054/bjoc.2000.1491'


 

This table displays all metadata directly associated to this object as RDF triples.

268 TRIPLES      22 PREDICATES      117 URIs      102 LITERALS      23 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1054/bjoc.2000.1491 schema:about N0cae546f34f6483397982ddfb91c2e83
2 N3a1d5cfc3bd4452da6a9bb7573296da6
3 N417e632530bb467f8d3369988e44094a
4 N756b6e9c2459447aa20549f47f369e92
5 N80c3d53bd5f7407aa3fcfdbc9e21fd72
6 N8a9521941e6e4f568ce9fa07de036ce1
7 N8d1fb60718bb4dc88aa7a51f8ba6aa3d
8 N98e1ba94868d49cf95f544896b6e1ba1
9 N9a042d377f264613b4c6932ac9df058b
10 Nacf2ab09eab44c9493852892809d17cd
11 Ncc0041ccf29043218bd45bd34855bad7
12 Ndeccfcb87a7a4f7b878c476980ee279d
13 Ne7b82876a4004f15989a05915fcaacc2
14 Nf3b75ca46cd649a79ee869a9487f464b
15 Nf508cc0ae323434296d3e4c716510b76
16 Nf85ae161ce0141429317f7b9263d573f
17 anzsrc-for:11
18 anzsrc-for:1117
19 schema:author N2bd268cc60624f36a88400bcd6058de9
20 schema:citation sg:pub.10.1007/bf00051652
21 sg:pub.10.1038/bjc.1989.236
22 sg:pub.10.1038/bjc.1991.350
23 sg:pub.10.1038/bjc.1995.347
24 sg:pub.10.1038/bjc.1997.440
25 sg:pub.10.1038/sj.bjc.6690523
26 sg:pub.10.1038/sj.bjc.6690730
27 schema:datePublished 2000-11-22
28 schema:datePublishedReg 2000-11-22
29 schema:description Human papillomavirus (HPV) testing has been suggested for primary screening of cervical cancer. Prediction of future high-grade cervical lesions is crucial for effectiveness and cost. We performed a case control study in a retrospective cohort of women with at least two cervical smears, all but the last one being negative, from the organized cervical screening programme in Florence, Italy. We searched for high-risk HPV in all previous, archival, smears from cases (new histologically confirmed cervical intraepithelial neoplasia (CIN) grade II or worse) and in one previous smear from each control (last smear cytologically normal, matched by age and interval (latency) from last smear). We applied polymerase chain reaction (PCR), and the b-globin gene was used as a DNA preservation marker. High-risk HPV was identified in 71/92 (77.17%) previous smears from 79 cases and 17/332 controls (5.12%). The odds ratio (OR) was 63.76 (95% CI 30.57-132.96). Among cases the proportion of HPV-positive smears declined slightly with increasing latency. Among cases, HPV was found in 81.24% (95% CI 69.93-88.96%) of smears with latency < 4 years and in 67.80% (95% CI 47.72-82.93%) of those taken at longer intervals, up to 6 years. These findings suggest that testing for high-risk HPV allows predicting 80% of CINII/III 3 years before the cytological diagnosis and two thirds 6 years before. They also suggest that testing women negative for high-risk HPV at longer interval and strictly following-up women who are HPV positive could be an effective strategy for cervical cancer screening.
30 schema:genre article
31 schema:inLanguage en
32 schema:isAccessibleForFree true
33 schema:isPartOf Nc96f3bfe6b534b918aab5830cf758da7
34 Nf2b1eb40b93a43d7a018b350bf0c3285
35 sg:journal.1017082
36 schema:keywords CINII/III 3 years
37 DNA preservation marker
38 Florence
39 HPV
40 HPV-positive smears
41 III 3 years
42 Italy
43 archival
44 cancer
45 cancer screening
46 case control study
47 cases
48 cervical cancer
49 cervical cancer screening
50 cervical intraepithelial neoplasia
51 cervical lesions
52 cervical screening programme
53 cervical smears
54 chain reaction
55 cohort
56 control
57 control study
58 cost
59 cytological diagnosis
60 diagnosis
61 effective strategy
62 effectiveness
63 findings
64 future high-grade cervical lesions
65 genes
66 globin genes
67 high-grade cervical intraepithelial neoplasia
68 high-grade cervical lesions
69 high-risk HPV
70 human papillomavirus testing
71 human papillomavirusesting
72 intervals
73 intraepithelial neoplasia
74 last one
75 latency
76 lesions
77 longer intervals
78 markers
79 neoplasia
80 normal women
81 odds ratio
82 one
83 papillomavirus (HPV) testing
84 papillomavirusesting
85 polymerase chain reaction
86 prediction
87 preservation marker
88 previous smears
89 primary screening
90 program
91 proportion
92 ratio
93 reaction
94 retrospective cohort
95 screening
96 screening program
97 smears
98 strategies
99 study
100 testing
101 thirds 6 years
102 women
103 years
104 schema:name Prediction of high-grade cervical intraepithelial neoplasia in cytologically normal women by human papillomavirusesting
105 schema:pagination 1462-1467
106 schema:productId N4042503785b945298884298b0da51b98
107 N955c4f2b625946c48fa9492fb3d5b585
108 Neb578344434a421c9e7e4a11fa334501
109 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007954422
110 https://doi.org/10.1054/bjoc.2000.1491
111 schema:sdDatePublished 2022-01-01T18:09
112 schema:sdLicense https://scigraph.springernature.com/explorer/license/
113 schema:sdPublisher N6f396cf0c71745c1958deb3d3670d29e
114 schema:url https://doi.org/10.1054/bjoc.2000.1491
115 sgo:license sg:explorer/license/
116 sgo:sdDataset articles
117 rdf:type schema:ScholarlyArticle
118 N0cae546f34f6483397982ddfb91c2e83 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
119 schema:name Female
120 rdf:type schema:DefinedTerm
121 N2bd268cc60624f36a88400bcd6058de9 rdf:first sg:person.0673306461.39
122 rdf:rest N62bc2d56e872469cb82774b53455e608
123 N3a1d5cfc3bd4452da6a9bb7573296da6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
124 schema:name Cervix Uteri
125 rdf:type schema:DefinedTerm
126 N4042503785b945298884298b0da51b98 schema:name pubmed_id
127 schema:value 11076654
128 rdf:type schema:PropertyValue
129 N417e632530bb467f8d3369988e44094a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
130 schema:name Tumor Virus Infections
131 rdf:type schema:DefinedTerm
132 N62bc2d56e872469cb82774b53455e608 rdf:first sg:person.01206540103.18
133 rdf:rest N8dece3df473540ccbd28d66c23097d90
134 N6f396cf0c71745c1958deb3d3670d29e schema:name Springer Nature - SN SciGraph project
135 rdf:type schema:Organization
136 N756b6e9c2459447aa20549f47f369e92 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
137 schema:name Time Factors
138 rdf:type schema:DefinedTerm
139 N80c3d53bd5f7407aa3fcfdbc9e21fd72 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
140 schema:name Case-Control Studies
141 rdf:type schema:DefinedTerm
142 N83394cdd95aa4ad383ef56f6acbf7486 rdf:first sg:person.0743542266.47
143 rdf:rest rdf:nil
144 N8a9521941e6e4f568ce9fa07de036ce1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
145 schema:name DNA, Viral
146 rdf:type schema:DefinedTerm
147 N8d1fb60718bb4dc88aa7a51f8ba6aa3d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
148 schema:name Papillomaviridae
149 rdf:type schema:DefinedTerm
150 N8dece3df473540ccbd28d66c23097d90 rdf:first sg:person.0667445361.38
151 rdf:rest Nd44da5a8b2124085bae11a12b3933d4a
152 N955c4f2b625946c48fa9492fb3d5b585 schema:name dimensions_id
153 schema:value pub.1007954422
154 rdf:type schema:PropertyValue
155 N98e1ba94868d49cf95f544896b6e1ba1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
156 schema:name Papillomavirus Infections
157 rdf:type schema:DefinedTerm
158 N9a042d377f264613b4c6932ac9df058b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
159 schema:name Adult
160 rdf:type schema:DefinedTerm
161 Nacf2ab09eab44c9493852892809d17cd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
162 schema:name Retrospective Studies
163 rdf:type schema:DefinedTerm
164 Nbe2664c8b52746d8a3500f60f3f9cce3 rdf:first sg:person.01116545420.18
165 rdf:rest Nc7b2343c8b2c4240beed3398162ebbf9
166 Nc7b2343c8b2c4240beed3398162ebbf9 rdf:first sg:person.01174274056.26
167 rdf:rest N83394cdd95aa4ad383ef56f6acbf7486
168 Nc96f3bfe6b534b918aab5830cf758da7 schema:volumeNumber 83
169 rdf:type schema:PublicationVolume
170 Ncc0041ccf29043218bd45bd34855bad7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
171 schema:name Humans
172 rdf:type schema:DefinedTerm
173 Nd44da5a8b2124085bae11a12b3933d4a rdf:first sg:person.01303355111.07
174 rdf:rest Nbe2664c8b52746d8a3500f60f3f9cce3
175 Ndeccfcb87a7a4f7b878c476980ee279d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
176 schema:name Globins
177 rdf:type schema:DefinedTerm
178 Ne7b82876a4004f15989a05915fcaacc2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
179 schema:name Uterine Cervical Neoplasms
180 rdf:type schema:DefinedTerm
181 Neb578344434a421c9e7e4a11fa334501 schema:name doi
182 schema:value 10.1054/bjoc.2000.1491
183 rdf:type schema:PropertyValue
184 Nf2b1eb40b93a43d7a018b350bf0c3285 schema:issueNumber 11
185 rdf:type schema:PublicationIssue
186 Nf3b75ca46cd649a79ee869a9487f464b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
187 schema:name Predictive Value of Tests
188 rdf:type schema:DefinedTerm
189 Nf508cc0ae323434296d3e4c716510b76 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
190 schema:name Middle Aged
191 rdf:type schema:DefinedTerm
192 Nf85ae161ce0141429317f7b9263d573f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
193 schema:name Cervical Intraepithelial Neoplasia
194 rdf:type schema:DefinedTerm
195 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
196 schema:name Medical and Health Sciences
197 rdf:type schema:DefinedTerm
198 anzsrc-for:1117 schema:inDefinedTermSet anzsrc-for:
199 schema:name Public Health and Health Services
200 rdf:type schema:DefinedTerm
201 sg:journal.1017082 schema:issn 0007-0920
202 1532-1827
203 schema:name British Journal of Cancer
204 schema:publisher Springer Nature
205 rdf:type schema:Periodical
206 sg:person.01116545420.18 schema:affiliation grid-institutes:None
207 schema:familyName Maddau
208 schema:givenName C
209 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01116545420.18
210 rdf:type schema:Person
211 sg:person.01174274056.26 schema:affiliation grid-institutes:None
212 schema:familyName Ciatto
213 schema:givenName S
214 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01174274056.26
215 rdf:type schema:Person
216 sg:person.01206540103.18 schema:affiliation grid-institutes:None
217 schema:familyName Ronco
218 schema:givenName G
219 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01206540103.18
220 rdf:type schema:Person
221 sg:person.01303355111.07 schema:affiliation grid-institutes:None
222 schema:familyName Noferini
223 schema:givenName D
224 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01303355111.07
225 rdf:type schema:Person
226 sg:person.0667445361.38 schema:affiliation grid-institutes:None
227 schema:familyName Confortini
228 schema:givenName M
229 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0667445361.38
230 rdf:type schema:Person
231 sg:person.0673306461.39 schema:affiliation grid-institutes:None
232 schema:familyName Carozzi
233 schema:givenName F
234 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0673306461.39
235 rdf:type schema:Person
236 sg:person.0743542266.47 schema:affiliation grid-institutes:None
237 schema:familyName Segnan
238 schema:givenName N
239 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0743542266.47
240 rdf:type schema:Person
241 sg:pub.10.1007/bf00051652 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032711152
242 https://doi.org/10.1007/bf00051652
243 rdf:type schema:CreativeWork
244 sg:pub.10.1038/bjc.1989.236 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022777795
245 https://doi.org/10.1038/bjc.1989.236
246 rdf:type schema:CreativeWork
247 sg:pub.10.1038/bjc.1991.350 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042218657
248 https://doi.org/10.1038/bjc.1991.350
249 rdf:type schema:CreativeWork
250 sg:pub.10.1038/bjc.1995.347 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010276001
251 https://doi.org/10.1038/bjc.1995.347
252 rdf:type schema:CreativeWork
253 sg:pub.10.1038/bjc.1997.440 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010481383
254 https://doi.org/10.1038/bjc.1997.440
255 rdf:type schema:CreativeWork
256 sg:pub.10.1038/sj.bjc.6690523 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041726872
257 https://doi.org/10.1038/sj.bjc.6690523
258 rdf:type schema:CreativeWork
259 sg:pub.10.1038/sj.bjc.6690730 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011080887
260 https://doi.org/10.1038/sj.bjc.6690730
261 rdf:type schema:CreativeWork
262 grid-institutes:None schema:alternateName Cancer Epidemiology Unit, ASL TO1, Centre for Cancer Epidemiology and Prevention (CPO), Torino, Italy
263 Cytology Unit, Centre for Cancer Study and Prevention (CSPO), Firenze, Italy
264 Department of Diagnostic Medical Imaging, Centre for Cancer Study and Prevention (CSPO), Florence, Italy
265 schema:name Cancer Epidemiology Unit, ASL TO1, Centre for Cancer Epidemiology and Prevention (CPO), Torino, Italy
266 Cytology Unit, Centre for Cancer Study and Prevention (CSPO), Firenze, Italy
267 Department of Diagnostic Medical Imaging, Centre for Cancer Study and Prevention (CSPO), Florence, Italy
268 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...